Pitolisant
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
- Assessment Report – Sunosi
- Wakix, INN-Pitolisant Hydrochloride
- Wakefulness-Promoting Agents – Wakix® (Pitolisant Tablets)
- Structural Modifications and in Vitro Pharmacological Evaluation of 4
- Central Histaminergic Signaling, Neural Excitability and Epilepsy
- The European Histamine Research Society 48Th Annual Meeting, May 15–18Th, 2019 Krako´W, Poland
- Efficacy of Pitolisant on the Treatment of Narcolepsy: a Systematic Review
- Wakix (Pitolisant) Xyrem (Sodium Oxybate) Xywav
- (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
- Pharmaabkommen A1 E
- Histamine H3 Receptor Antagonists/Inverse Agonists
- Substance Abuse in the Workplaces of Our Bodies and Mind
- Stimulants and Related Agents
- Therapeutic Class Review
- Effects of Pitolisant, a Histamine H3 Inverse Agonist, in Drug-Resistant
- Pitolisant Protects Mice Chronically Treated with Corticosterone From
- Orange Book Cumulative Supplement 7 July 2021